SubHero Banner
Text

Otezla® (apremilast) – New warning

June 29, 2017 – The FDA approved an update to the Warnings and Precautions section of the Otezla (apremilast) drug label regarding the risk of diarrhea, nausea and vomiting.

Download PDF